YU25500A - Postupak za sintezu analoga nukleozida - Google Patents
Postupak za sintezu analoga nukleozidaInfo
- Publication number
- YU25500A YU25500A YU25500A YUP25500A YU25500A YU 25500 A YU25500 A YU 25500A YU 25500 A YU25500 A YU 25500A YU P25500 A YUP25500 A YU P25500A YU 25500 A YU25500 A YU 25500A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- nucleosite
- synthesis
- analogues
- protected
- heterocycluse
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Ovaj pronalazak se odnosi na unapredjenje metoda za sintezu nukleozida sa niskim odnosom α:Гџ anomera. Metod sadrži spajanje zaštićenog furanozil halida i odgovarajućeg zaštićenog heterociklusa u prisustvu nukleofilnog polarnog rastvarača i jake baze.[The invention refers to the improvement of the method for nucleosite synthesis with the low ratio of L- B anomeres. Method contents connecting protected furanozile halide and suitable protected heterocycluse in the presence of nucleofile polar solvent and strong base.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13365199P | 1999-05-11 | 1999-05-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU25500A true YU25500A (sh) | 2003-08-29 |
Family
ID=22459680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU25500A YU25500A (sh) | 1999-05-11 | 2000-05-03 | Postupak za sintezu analoga nukleozida |
Country Status (22)
Country | Link |
---|---|
US (1) | US6271370B1 (sh) |
EP (1) | EP1052264B1 (sh) |
JP (1) | JP2001011092A (sh) |
KR (1) | KR100403900B1 (sh) |
CN (1) | CN1275575A (sh) |
AR (1) | AR028991A1 (sh) |
AT (1) | ATE291582T1 (sh) |
AU (1) | AU3401100A (sh) |
BR (1) | BR0002089A (sh) |
CA (1) | CA2307951A1 (sh) |
CZ (1) | CZ20001710A3 (sh) |
DE (1) | DE60018833D1 (sh) |
HU (1) | HUP0001843A3 (sh) |
ID (1) | ID25992A (sh) |
IL (1) | IL136027A0 (sh) |
IN (1) | IN186850B (sh) |
MX (1) | MXPA00004532A (sh) |
PL (1) | PL340109A1 (sh) |
RU (1) | RU2200738C2 (sh) |
TR (1) | TR200001340A2 (sh) |
YU (1) | YU25500A (sh) |
ZA (1) | ZA200002263B (sh) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200519106A (en) | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
GB0401334D0 (en) | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
GB0424284D0 (en) | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
WO2006122003A2 (en) | 2005-05-05 | 2006-11-16 | Ardea Biosciences, Inc. | Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv |
GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
EP1924553A1 (en) | 2005-08-08 | 2008-05-28 | Argenta Discovery Limited | Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
AR058104A1 (es) | 2005-10-21 | 2008-01-23 | Novartis Ag | Compuestos organicos |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
JP2010504933A (ja) | 2006-09-29 | 2010-02-18 | ノバルティス アーゲー | Pi3k脂質キナーゼ阻害剤としてのピラゾロピリミジン |
EP2089393A1 (en) | 2006-10-30 | 2009-08-19 | Novartis AG | Heterocyclic compounds as antiinflammatory agents |
WO2009079412A2 (en) | 2007-12-14 | 2009-06-25 | Ardea Biosciences Inc. | Reverse transcriptase inhibitors |
US8394836B2 (en) | 2007-12-14 | 2013-03-12 | Pulmagen Therapeutics (Asthma) Limited | Indoles and their therapeutic use |
PL2231642T3 (pl) | 2008-01-11 | 2014-04-30 | Novartis Ag | Pirymidyny jako inhibitory kinazy |
US20110281917A1 (en) | 2009-01-29 | 2011-11-17 | Darrin Stuart | Substituted Benzimidazoles for the Treatment of Astrocytomas |
PE20120655A1 (es) | 2009-02-17 | 2012-06-07 | Chiesi Farma Spa | Derivados de triazolopiridina como inhibidores de proteinas cinasas activadas por mitogeno p38 (map) |
GB0902648D0 (en) | 2009-02-17 | 2009-04-01 | Argenta Discovery Ltd | Pharmaceutical compounds and compositions |
WO2011005860A2 (en) * | 2009-07-07 | 2011-01-13 | Alnylam Pharmaceuticals, Inc. | 5' phosphate mimics |
US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
AU2010283806A1 (en) | 2009-08-12 | 2012-03-01 | Novartis Ag | Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation |
SG178454A1 (en) | 2009-08-17 | 2012-03-29 | Intellikine Inc | Heterocyclic compounds and uses thereof |
JP5775871B2 (ja) | 2009-08-20 | 2015-09-09 | ノバルティス アーゲー | ヘテロ環式オキシム化合物 |
GB201009731D0 (en) | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
WO2012107500A1 (en) | 2011-02-10 | 2012-08-16 | Novartis Ag | [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase |
WO2012116237A2 (en) | 2011-02-23 | 2012-08-30 | Intellikine, Llc | Heterocyclic compounds and uses thereof |
WO2012116217A1 (en) | 2011-02-25 | 2012-08-30 | Irm Llc | Compounds and compositions as trk inhibitors |
JP5957526B2 (ja) | 2011-09-15 | 2016-07-27 | ノバルティス アーゲー | チロシンキナーゼとしての6−置換3−(キノリン−6−イルチオ)−[1,2,4]トリアゾロ[4,3−a]ピラジン |
WO2013078440A2 (en) | 2011-11-23 | 2013-05-30 | Intellikine, Llc | Enhanced treatment regimens using mtor inhibitors |
SG11201402986RA (en) | 2011-12-09 | 2014-12-30 | Chiesi Farma Spa | Kinase inhibitors |
CN103987708B (zh) | 2011-12-09 | 2016-06-22 | 奇斯药制品公司 | 4-羟基-1,2,3,4-四氢萘-1-基脲的衍生物及其在呼吸道疾病治疗中的用途 |
GEP201706735B (en) | 2011-12-09 | 2017-09-25 | Chiesi Farm Spa | Kinase inhibitors |
CN110507654A (zh) | 2012-04-03 | 2019-11-29 | 诺华有限公司 | 有酪氨酸激酶抑制剂的组合产品和其应用 |
AU2013282869B2 (en) | 2012-06-29 | 2015-12-24 | Pfizer Inc. | Novel 4-(substituted-amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors |
JP2016512835A (ja) | 2013-03-15 | 2016-05-09 | インテリカイン, エルエルシー | キナーゼ阻害剤の組み合わせ及びそれらの使用 |
RU2015151886A (ru) | 2013-06-06 | 2017-06-08 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Ингибиторы киназ |
CA2922770A1 (en) | 2013-09-05 | 2015-03-12 | F. Hoffmann-La Roche Ag | Triazolopyridine compounds, compositions and methods of use thereof |
TW201605450A (zh) | 2013-12-03 | 2016-02-16 | 諾華公司 | Mdm2抑制劑與BRAF抑制劑之組合及其用途 |
CA2933767C (en) | 2013-12-17 | 2018-11-06 | Pfizer Inc. | Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors |
WO2016011658A1 (en) | 2014-07-25 | 2016-01-28 | Novartis Ag | Combination therapy |
US10195208B2 (en) | 2014-07-31 | 2019-02-05 | Novartis Ag | Combination therapy |
EP3265464A1 (en) | 2015-03-04 | 2018-01-10 | F. Hoffmann-La Roche AG | Triazolopyridine compounds and methods of use thereof |
KR102161364B1 (ko) | 2015-09-14 | 2020-09-29 | 화이자 인코포레이티드 | LRRK2 억제제로서 이미다조[4,5-c]퀴놀린 및 이미다조[4,5-c][1,5]나프티리딘 유도체 |
TW201720828A (zh) | 2015-11-23 | 2017-06-16 | 赫孚孟拉羅股份公司 | 治療性化合物及組合物以及其使用方法 |
WO2017108736A1 (en) | 2015-12-23 | 2017-06-29 | Chiesi Farmaceutici S.P.A. | N-[3-(3-{4-[[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl} -ureido)-phenyl]-methanesulfonamide derivatives and their use as p38 mapk inhibitors |
EP3394060A1 (en) | 2015-12-23 | 2018-10-31 | Chiesi Farmaceutici S.p.A. | 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urea derivatives and their use as p38 mapk inhibitors |
EP3394059B1 (en) | 2015-12-23 | 2020-11-25 | Chiesi Farmaceutici S.p.A. | 1-(3-tert-butyl-phenyl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro- naphthalen-1-yl)-urea derivatives and their use as p38 mapk inhibitors |
CN109476638B (zh) | 2016-05-05 | 2021-12-28 | 豪夫迈·罗氏有限公司 | 吡唑衍生物、其组合物及治疗用途 |
PE20190632A1 (es) | 2016-09-06 | 2019-04-26 | Hoffmann La Roche | Compuestos 8-(azetidin-1-il)-[1,2,4]triazolo[1,5-a]piridinilo, composiciones y metodos de utilizacion de los mismos |
MX2019007339A (es) | 2016-12-29 | 2019-09-06 | Hoffmann La Roche | Compuestos de pirazolopirimidina y metodos de uso de los mismos. |
CN110494434B (zh) | 2017-03-14 | 2022-05-24 | 豪夫迈·罗氏有限公司 | 吡唑并氯苯基化合物、其组合物及其使用方法 |
KR20200010390A (ko) | 2017-05-22 | 2020-01-30 | 에프. 호프만-라 로슈 아게 | 치료 화합물 및 조성물, 및 이의 사용 방법 |
US20180334465A1 (en) | 2017-05-22 | 2018-11-22 | Genentech, Inc. | Therapeutic compounds and compositions, and methods of use thereof |
US10364245B2 (en) | 2017-06-07 | 2019-07-30 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
JP7339263B2 (ja) | 2018-01-15 | 2023-09-05 | エフ. ホフマン-ラ ロシュ アーゲー | Jak阻害剤としてのピラゾロピリミジン化合物 |
WO2020257142A1 (en) | 2019-06-18 | 2020-12-24 | Genentech, Inc. | Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereof |
EP3986899A1 (en) | 2019-06-18 | 2022-04-27 | F. Hoffmann-La Roche AG | Pyrazolopyrimidine aryl ether inhibitors of jak kinases and uses thereof |
AU2020297415A1 (en) | 2019-06-18 | 2022-01-06 | F. Hoffmann-La Roche Ag | Pyrazolopyrimidine sulfone inhibitors of JAK kinases and uses thereof |
TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗tslp抗體治療炎性或阻塞性氣道疾病之方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61207400A (ja) * | 1985-03-11 | 1986-09-13 | Nippon Zoki Pharmaceut Co Ltd | ヌクレオシド化合物の製造方法 |
US4751292A (en) | 1985-07-02 | 1988-06-14 | The Plant Cell Research Institute, Inc. | Adamantyl purines |
US4859677A (en) | 1987-04-17 | 1989-08-22 | University Of Kansas | Nucleoside analogues having antiviral activity |
US5246931A (en) | 1988-10-25 | 1993-09-21 | Bristol-Myers Squibb Company | Carbocyclic nucleoside analogs |
US5688778A (en) | 1989-05-15 | 1997-11-18 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Nucleoside analogs |
GB8916480D0 (en) | 1989-07-19 | 1989-09-06 | Glaxo Group Ltd | Chemical process |
US5674998A (en) | 1989-09-15 | 1997-10-07 | Gensia Inc. | C-4' modified adenosine kinase inhibitors |
US5763596A (en) | 1989-09-15 | 1998-06-09 | Metabasis Therapeutics, Inc. | C-4' modified adenosine kinase inhibitors |
US5276151A (en) | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US5470857A (en) | 1990-09-14 | 1995-11-28 | Marion Merrell Dow Inc. | Carbocyclic nucleoside analogs useful as immunosuppressants |
SE9003151D0 (sv) | 1990-10-02 | 1990-10-02 | Medivir Ab | Nucleoside derivatives |
ZA923641B (en) | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
GB9204015D0 (en) | 1992-02-25 | 1992-04-08 | Wellcome Found | Therapeutic nucleosides |
TW374087B (en) | 1993-05-25 | 1999-11-11 | Univ Yale | L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents |
AU3086495A (en) * | 1994-08-02 | 1996-03-04 | Banyu Pharmaceutical Co., Ltd. | Antitumor indolopyrrolocarbazoles |
US5659023A (en) | 1995-02-01 | 1997-08-19 | Gilead Sciences, Inc. | Nucleotide analogues |
EP1019425A1 (en) | 1996-01-23 | 2000-07-19 | The Regents Of The University Of Michigan | Modified benzimidazole nucleosides as antiviral agents |
-
2000
- 2000-05-03 YU YU25500A patent/YU25500A/sh unknown
- 2000-05-08 IN IN421MU2000 patent/IN186850B/en unknown
- 2000-05-08 US US09/566,468 patent/US6271370B1/en not_active Expired - Fee Related
- 2000-05-08 IL IL13602700A patent/IL136027A0/xx unknown
- 2000-05-09 JP JP2000135874A patent/JP2001011092A/ja active Pending
- 2000-05-09 ZA ZA200002263A patent/ZA200002263B/xx unknown
- 2000-05-09 AT AT00303892T patent/ATE291582T1/de not_active IP Right Cessation
- 2000-05-09 EP EP00303892A patent/EP1052264B1/en not_active Expired - Lifetime
- 2000-05-09 DE DE60018833T patent/DE60018833D1/de not_active Expired - Lifetime
- 2000-05-09 AR ARP000102222A patent/AR028991A1/es active IP Right Grant
- 2000-05-09 CA CA002307951A patent/CA2307951A1/en not_active Abandoned
- 2000-05-09 BR BR0002089-3A patent/BR0002089A/pt not_active IP Right Cessation
- 2000-05-10 ID IDP20000389D patent/ID25992A/id unknown
- 2000-05-10 CZ CZ20001710A patent/CZ20001710A3/cs unknown
- 2000-05-10 AU AU34011/00A patent/AU3401100A/en not_active Abandoned
- 2000-05-10 MX MXPA00004532A patent/MXPA00004532A/es unknown
- 2000-05-10 CN CN00107145A patent/CN1275575A/zh active Pending
- 2000-05-10 HU HU0001843A patent/HUP0001843A3/hu unknown
- 2000-05-10 KR KR10-2000-0024885A patent/KR100403900B1/ko not_active IP Right Cessation
- 2000-05-10 RU RU2000111438/04A patent/RU2200738C2/ru not_active IP Right Cessation
- 2000-05-11 PL PL00340109A patent/PL340109A1/xx not_active Application Discontinuation
- 2000-05-11 TR TR2000/01340A patent/TR200001340A2/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL136027A0 (en) | 2001-05-20 |
HU0001843D0 (en) | 2000-07-28 |
ZA200002263B (en) | 2001-12-24 |
DE60018833D1 (de) | 2005-04-28 |
ID25992A (id) | 2000-11-16 |
TR200001340A2 (tr) | 2000-12-21 |
MXPA00004532A (es) | 2002-03-08 |
IN186850B (sh) | 2001-11-24 |
AR028991A1 (es) | 2003-06-04 |
EP1052264A3 (en) | 2001-06-13 |
EP1052264B1 (en) | 2005-03-23 |
PL340109A1 (en) | 2000-11-20 |
HUP0001843A2 (hu) | 2001-06-28 |
US6271370B1 (en) | 2001-08-07 |
KR20010069193A (ko) | 2001-07-23 |
HUP0001843A3 (en) | 2001-09-28 |
ATE291582T1 (de) | 2005-04-15 |
RU2200738C2 (ru) | 2003-03-20 |
AU3401100A (en) | 2000-11-16 |
KR100403900B1 (ko) | 2003-11-01 |
JP2001011092A (ja) | 2001-01-16 |
CA2307951A1 (en) | 2000-11-11 |
CZ20001710A3 (cs) | 2001-09-12 |
CN1275575A (zh) | 2000-12-06 |
EP1052264A2 (en) | 2000-11-15 |
BR0002089A (pt) | 2001-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU25500A (sh) | Postupak za sintezu analoga nukleozida | |
MXPA04008772A (es) | Composiciones de clorhidrato de naltrexona. | |
HUP0200297A3 (en) | Method for acylating peptides and the glutaminic acid derivatives as acylating agents | |
IL128829A0 (en) | Improved solid-phase peptide and agent for use in such synthesis | |
TW437388U (en) | Structure of universal, horizontal, electrical transportation vehicle | |
AU2001245928A1 (en) | Electrolyzer and method of using the same | |
MY134559A (en) | Lactam compound to inhibit beta-amyloid peptide release or synthesis | |
IL130102A (en) | Aminoguanidines and alkoxyguanidines as protease inhibitors, pharmaceutical compositions containing the same and processes for preparing the same | |
WO2005051358A8 (en) | Composition and method for enhancing bioavailability | |
GB0201029D0 (en) | Structure for waterproofing terminal-wire connecting portion and method of waterproofing the same | |
TNSN05254A1 (en) | Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics | |
IL148803A0 (en) | Novel composition and method for stabilizing the same | |
MY122278A (en) | 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position | |
GB0015426D0 (en) | Method for generating soluble highly multimeric proteins | |
AU5956001A (en) | Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists | |
AU2002218075A1 (en) | Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them | |
DE69927602D1 (de) | Verfahren zur herstellung von vitaminpulvern | |
AU4859200A (en) | Process for enhancing the value of hydrocarbonaceous natural resources | |
GB2397059B (en) | Method to improve the stability of dispersions of carbon | |
WO2004092727A3 (en) | Compound libraries and methods for drug discovery | |
MY124078A (en) | Eletriptan hydrobromide monohydrate | |
GR20010100601A (el) | Προτυπα αναφορας για τον προσδιορισμο της καθαροτητας ή σταθεροτητας της μιλεινικης αμλοδιπινης και διεργασιες για αυτα. | |
PL347179A1 (en) | Tricyclic &dgr;3-piperidines as pharmaceuticals | |
ID27440A (id) | Proses untuk menyiapkan penengah-penengah | |
AU4242301A (en) | Method for producing amines by the hydroaminomethylation of olefins in the presence of ionic liquids |